Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

The amino-acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesothelioma

Lyssa T Gold1, Susan E Bray2, Neil M Kernohan3

  • 1Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland.

BJC Reports
|November 8, 2024
PubMed
Abstract

Insights

General Control Non-derepressible 2 (GCN2) protein levels correlate with survival in malignant mesothelioma patients. Higher GCN2 expression indicates a poorer prognosis, suggesting GCN2 as a therapeutic target for this asbestos-related cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant mesothelioma is an asbestos-associated cancer with a poor prognosis.
  • This cancer originates from mesothelial cells lining body cavities, most commonly the pleura.
  • Many mesotheliomas exhibit arginine auxotrophy, presenting a potential therapeutic vulnerability.

Purpose of the Study:

  • To investigate the role of General Control Non-derepressible 2 (GCN2) protein in malignant mesothelioma.
  • To determine if GCN2 protein levels correlate with patient survival and clinical outcomes.

Main Methods:

  • Measurement of GCN2 protein levels in malignant mesothelioma tumor samples.
  • Correlation analysis between GCN2 expression and clinical data, including patient survival.

Main Results:

  • GCN2 protein expression levels were found to correlate significantly with patient survival.
  • GCN2 served as an independent prognostic variable when compared with all available clinical data.

Conclusions:

  • GCN2 protein levels offer valuable prognostic information for malignant mesothelioma.
  • GCN2 expression may aid in stratifying patients for tailored care pathways.
  • Targeting GCN2 represents a promising therapeutic strategy for developing new mesothelioma treatments.

More Related Videos

Measurements of Physiological Stress Responses in C. Elegans10:36

Measurements of Physiological Stress Responses in C. Elegans

Published on: May 21, 2020

13.8K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K